DLA
Douglas Lane & Associates Portfolio holdings
AUM
$6.9B
This Quarter Return
+7.05%
1 Year Return
+13.87%
3 Year Return
+73.39%
5 Year Return
+145.47%
10 Year Return
–
AUM
$6.19B
AUM Growth
+$6.19B
(+3%)
Cap. Flow
-$121M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
21.67%
Holding
241
New
11
Increased
68
Reduced
137
Closed
2
Top Buys
| 1 |
RXO
RXO
|
$19M |
| 2 |
Cleveland-Cliffs
CLF
|
$11.7M |
| 3 |
CVS Health
CVS
|
$8.72M |
| 4 |
Alcoa
AA
|
$7.84M |
| 5 |
Charter Communications
CHTR
|
$7.38M |
Top Sells
| 1 |
MAXR
Maxar Technologies Inc. Common Stock
MAXR
|
$82.8M |
| 2 |
Electronic Arts
EA
|
$24M |
| 3 |
NVIDIA
NVDA
|
$18.9M |
| 4 |
Oracle
ORCL
|
$17.2M |
| 5 |
Microsoft
MSFT
|
$6.65M |
Sector Composition
| 1 | Financials | 17.68% |
| 2 | Technology | 16.56% |
| 3 | Healthcare | 15.52% |
| 4 | Industrials | 11.68% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Transact Technologies
TACT
$45M
| $108K | ﹤0.01% |
12,081
| – | – |
|
|
SIVB
227
DELISTED
SVB Financial Group
SIVB
| $41.9K | ﹤0.01% |
80,917
-55,726
| -41% | -$28.9K |
|
|
ADAP
228
Adaptimmune Therapeutics
ADAP
$13.9M
| $12K | ﹤0.01% |
13,000
| – | – |
|
229
Heron Therapeutics
HRTX
$204M
| $11.6K | ﹤0.01% |
10,000
| – | – |
|
|
LQMT
230
DELISTED
LIQUIDMETAL TECHNOLOGIES INC
LQMT
| $585 | ﹤0.01% |
10,000
| – | – |
|
|
MAXR
231
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| – | – |
-1,621,272
| Closed | -$82.8M |
|
|
MNTV
232
DELISTED
Momentive Global Inc. Common Stock
MNTV
| – | – |
-229,560
| Closed | -$2.14M |
|